Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy

doi:10.1016/j.drudis.2020.12.006

Review

. 2021 Mar;26(3):817-825.

doi: 10.1016/j.drudis.2020.12.006. Epub 2020 Dec 11.

Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy

Chengcan Yang¹, Jifa Zhang¹, Minru Liao¹, Yushang Yang², Yuxi Wang³, Yong Yuan⁴, Liang Ouyang⁵

Affiliations

¹ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China.
² State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, China.
³ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, China. Electronic address: yuxiwang@scu.edu.cn.
⁴ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, China. Electronic address: yongyuan@scu.edu.cn.
⁵ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; The Research Units of West China, Chinese Academy of Medical Sciences, China. Electronic address: ouyangliang@scu.edu.cn.

PMID: 33316375
DOI: 10.1016/j.drudis.2020.12.006

Review

Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy

Chengcan Yang et al. Drug Discov Today. 2021 Mar.

. 2021 Mar;26(3):817-825.

doi: 10.1016/j.drudis.2020.12.006. Epub 2020 Dec 11.

Authors

Chengcan Yang¹, Jifa Zhang¹, Minru Liao¹, Yushang Yang², Yuxi Wang³, Yong Yuan⁴, Liang Ouyang⁵

Affiliations

¹ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China.
² State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, China.
³ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, China. Electronic address: yuxiwang@scu.edu.cn.
⁴ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, China. Electronic address: yongyuan@scu.edu.cn.
⁵ State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, China; The Research Units of West China, Chinese Academy of Medical Sciences, China. Electronic address: ouyangliang@scu.edu.cn.

PMID: 33316375
DOI: 10.1016/j.drudis.2020.12.006

Abstract

Folate-mediated one-carbon metabolism (FOCM) supports vital events for the growth and survival of proliferating cells. Nucleotide synthesis and DNA methylation are the biochemical bases of cancers that are highly dependent on FOCM. Recent studies revealed that FOCM is connected with redox homeostasis and epigenetics in cancer. Furthermore, folate-metabolizing enzymes, such as serine hydroxymethyltransferase 2 (SHMT2) and methylenetetrahydrofolate dehydrogenase 2 (MTHFD2), are associated with the development of cancers, including breast cancer, highlighting their potential application in tumor-targeted therapy. Therefore, targeting metabolizing enzymes, especially SHMT2 and MTHFD2, provides a novel strategy for cancer treatment. In this review, we outline current understanding of the functions of SHMT2 and MTHFD2, discussing their expression, potential functions, and regulatory mechanism in cancers. Furthermore, we discuss examples of inhibitors of SHMT2 and MTHFD2.

PubMed Disclaimer

Cited by

In Vitro and In Silico Analysis of the Anticancer Effects of Eurycomanone and Eurycomalactone from Eurycoma longifolia.
Yunos NM, Wahab HA, Al-Thiabat MG, Sallehudin NJ, Jauri MH. Yunos NM, et al. Plants (Basel). 2023 Jul 31;12(15):2827. doi: 10.3390/plants12152827. Plants (Basel). 2023. PMID: 37570981 Free PMC article.
Revealing protonation states and tracking substrate in serine hydroxymethyltransferase with room-temperature X-ray and neutron crystallography.
Drago VN, Campos C, Hooper M, Collins A, Gerlits O, Weiss KL, Blakeley MP, Phillips RS, Kovalevsky A. Drago VN, et al. Commun Chem. 2023 Aug 3;6(1):162. doi: 10.1038/s42004-023-00964-9. Commun Chem. 2023. PMID: 37532884 Free PMC article.
Targeting mitochondrial one-carbon enzyme MTHFD2 together with pemetrexed confers therapeutic advantages in lung adenocarcinoma.
Mo J, Gao Z, Zheng L, Yan M, Xue M, Xu J, Bao Y, Wu J. Mo J, et al. Cell Death Discov. 2022 Jul 5;8(1):307. doi: 10.1038/s41420-022-01098-y. Cell Death Discov. 2022. PMID: 35790743 Free PMC article.
A novel ligand-modified nanocomposite microparticles improved efficiency of quercetin and paclitaxel delivery in the non-small cell lung cancer.
Cui X, Zhang F, Zhao Y, Li P, Wang T, Xu Z, Zhang J, Zhang W. Cui X, et al. Drug Deliv. 2022 Dec;29(1):3123-3133. doi: 10.1080/10717544.2022.2120567. Drug Deliv. 2022. PMID: 36151722 Free PMC article.
De novo serine biosynthesis from glucose predicts sex-specific response to antifolates in non-small cell lung cancer cell lines.
Sponagel J, Devarakonda S, Rubin JB, Luo J, Ippolito JE. Sponagel J, et al. iScience. 2022 Oct 12;25(11):105339. doi: 10.1016/j.isci.2022.105339. eCollection 2022 Nov 18. iScience. 2022. PMID: 36325067 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy

Affiliations

Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources